Long non-coding RNA expressed in aggressive cancer
Abstract
The invention described in the application relates to a long non-coding RNA expressed in cancer. The invention thus provides methods and compositions for evaluating levels of the long non-coding RNA to assess the aggressiveness of a cancer and for modulating levels of the long non-coding RNA.
- Inventors:
- Issue Date:
- Research Org.:
- Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1568646
- Patent Number(s):
- 10364470
- Application Number:
- 15/353,710
- Assignee:
- The Regents of the University of California (Oakland, CA)
- Patent Classifications (CPCs):
-
C - CHEMISTRY C12 - BIOCHEMISTRY C12N - MICROORGANISMS OR ENZYMES
C - CHEMISTRY C12 - BIOCHEMISTRY C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
- DOE Contract Number:
- AC02-05CH11231; CA39681
- Resource Type:
- Patent
- Resource Relation:
- Patent File Date: 11/16/2016
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 59 BASIC BIOLOGICAL SCIENCES; 37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY
Citation Formats
Kohwi-Shigematsu, Terumi, Kohwi, Yoshinori, Ordinario, Ellen C., Balamotis, Michael A., and Han, Hye-Jung. Long non-coding RNA expressed in aggressive cancer. United States: N. p., 2019.
Web.
Kohwi-Shigematsu, Terumi, Kohwi, Yoshinori, Ordinario, Ellen C., Balamotis, Michael A., & Han, Hye-Jung. Long non-coding RNA expressed in aggressive cancer. United States.
Kohwi-Shigematsu, Terumi, Kohwi, Yoshinori, Ordinario, Ellen C., Balamotis, Michael A., and Han, Hye-Jung. Tue .
"Long non-coding RNA expressed in aggressive cancer". United States. https://www.osti.gov/servlets/purl/1568646.
@article{osti_1568646,
title = {Long non-coding RNA expressed in aggressive cancer},
author = {Kohwi-Shigematsu, Terumi and Kohwi, Yoshinori and Ordinario, Ellen C. and Balamotis, Michael A. and Han, Hye-Jung},
abstractNote = {The invention described in the application relates to a long non-coding RNA expressed in cancer. The invention thus provides methods and compositions for evaluating levels of the long non-coding RNA to assess the aggressiveness of a cancer and for modulating levels of the long non-coding RNA.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Tue Jul 30 00:00:00 EDT 2019},
month = {Tue Jul 30 00:00:00 EDT 2019}
}
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.
Works referenced in this record:
Control of CD44 gene expression for therapeutic use
patent, November 1999
- Ruzdijic, Sabera; Pietrzkowski, Zbigniew; Cieslak, Dariusz
- US Patent Document 5,990,299
Method and Materials for Assessing Cancer Aggressiveness
patent-application, February 2004
- Sinha, Akhouri; Wilson, Michael J.; Quast, Barry J.
- US Patent Application 10/332628; 20040038240
Vector for Expression of Heterologous Protein and Methods for Extracting Recombinant Protein and for Purifying Isolated Recombinant Insulin
patent-application, May 2003
- Astolfi, Spartaco F.; De Lima, Beatriz Dolabela; Thiemann, Josef Ernst
- US Patent Application 09/515534; 20030082742
Determining Cancer Aggressiveness
patent-application, October 2003
- Spelsberg, Thomas C.; Roche, Patrick C.; Reinholz, Monica
- US Patent Application 10/123626; 20030198961
Human thrombospondin polypeptide
patent, June 2010
- Mintz, Liat; Xie, Hanqing; Dahary, Dvir
- US Patent Document 7,745,391
Methods for Inhibiting Proliferation and Inducing Apoptosis in Cancer Cells
patent-application, March 2004
- Adrian, Thomas E.
- US Patent Application 10/275590; 20040053962